Graeme Kay

Dr. Graeme Kay


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

8 April 2019 in MedChemComm
Verified
Journal Article
Closed access
PDF file
MSMatteo Scipioni
Matteo Scipioni
GKGraeme Kay
Graeme Kay
Ian MegsonIan Megson
Ian Megson
PLPaul Kong Thoo Lin
Paul Kong Thoo Lin
Novel vanillin–tacrine hybrid acting as AChE and Aβ(1–42)amyloid aggregation inhibitor with strong antioxidant properties enhanced by thep-phenylenediamine linker.

1 January 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
MSMatteo Scipioni
Matteo Scipioni
GKGraeme Kay
Graeme Kay
Ian MegsonIan Megson
Ian Megson
PLPaul Kong Thoo Lin
Paul Kong Thoo Lin
Antioxidants have been the subject of intense research interest mainly due to their beneficial properties associated with human health and wellbeing. Phenolic molecules, such as naturally occurring Resveratrol and Vanillin, are well known for their anti-oxidant properties, providing a starting point for the development of new antioxidants. Here we report, for the first time, the synthesis of a number of new vanillin through the reductive amination reaction between vanillin and a selection of amines. All the compounds synthesised, exhibited strong antioxidant properties in DPPH, FRAP and ORAC assays, with compounds 1b and 2c being the most active. The latter also demonstrated the ability to protect plasmid DNA from oxidative damage in the presence of the radical initiator AAPH. At cellular level, neuroblastoma SH-SY5Y cells were protected from oxidative damage (H2O2, 400 μM) with both 1b and 2c. The presence of a tertiary amino group, along with the number of vanillin moieties in the molecule contribute for the antioxidant activity. Furthermore, the delocalization of the electron pair of the nitrogen and the presence of an electron donating substituent to enhance the antioxidant properties of this new class of compounds. In our opinion, vanillin derivatives 1b and 2c described in this work can provide a viable platform for the development of antioxidant based therapeutics.

14 October 2008 in CrystEngComm
Verified
Journal Article
Closed access
PDF file
MBMaureen Byres
Maureen Byres
PCPhilip J. Cox
Philip J. Cox
GKGraeme Kay
Graeme Kay
ENElaine Nixon
Elaine Nixon
Studies concentrating on hydrogen bonding between the bases of DNA and small molecule proton acceptor/donators have led to an increased understanding of the role such complexes have in DNA binding. Here anhydrous and solvated multicomponent crystals of adenine have been prepared with benzoic acid, adipic acid, salicylic acid, 2,6-dihydroxybenzoic acid and 3,5-dihydroxybenzoic acid. The six crystalline forms reported are an anhydrous cocrystal, a methanolated cocrystal, an anhydrous proton-transfer complex, a hydrated proton-transfer complex, a methanolated proton-transfer complex and a doubly hydrated salt. All products were formed in solution and obtained by the slow evaporation technique. A comparison of hydrogen bonding motifs in the products is presented.

15 June 2010 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
BBBarbara Buchan
Barbara Buchan
GKGraeme Kay
Graeme Kay
AHAnne Heneghan
Anne Heneghan
KMKerr H. Matthews
Kerr H. Matthews
DCDonald Cairns
Donald Cairns

1 March 2008 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
BMBridgeen McCaughan
Bridgeen McCaughan
GKGraeme Kay
Graeme Kay
RKRachel Knott
Rachel Knott
DCDonald Cairns
Donald Cairns